Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ansbert Gadicke currently holds 304,001 shares of Cullinan Oncology, Inc. (CGEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ansbert Gadicke has been a net seller of CGEM stock. They have purchased $71.8M and sold $101.2M worth of shares.
Ansbert Gadicke's most recent insider trade was on Jun 1, 2023, when they sold 304,001 shares at $0.00 per share.
Ansbert Gadicke serves as Executive at Cullinan Oncology, Inc. (CGEM). They have executed 250 insider transactions totaling $173.0M over their tenure at the company.
Ansbert Gadicke holds the position of Executive at Cullinan Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ansbert Gadicke has shown a selling trading pattern, with $71.8M in total purchases and $101.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ansbert Gadicke was on Jul 28, 2022, when they purchased $15.0M worth of ALVR shares. This transaction involved 3,253,796 shares at $4.61 per share.
Ansbert Gadicke currently owns 304,001 shares of Cullinan Oncology, Inc. (CGEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ansbert Gadicke's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ansbert Gadicke has 250 Form 4 filings on record as an insider at Cullinan Oncology, Inc..
Set alerts for Ansbert Gadicke and 40,000+ other insiders.